These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35231155)

  • 1. Atezolizumab induced de novo rupoid psoriasis: A rare cutaneous manifestation of immune checkpoint inhibitors.
    Mohta A; Arora A; Jain SK
    J Cosmet Dermatol; 2022 May; 21(5):2005-2008. PubMed ID: 35231155
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors.
    Cutroneo P; Ingrasciotta Y; Isgrò V; Rullo EV; Berretta M; Fiorica F; Trifirò G; Guarneri C
    Dermatol Ther; 2021 Mar; 34(2):e14830. PubMed ID: 33527643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of epidermal Langerhans cells in psoriasiform lesions of de novo induced or worsened pre-existing psoriasis following uses of immune checkpoint inhibitors.
    Kase M; Fujita Y; Ota A; Shimizu S; Itoi-Ochi S; Sano S
    J Dermatol; 2022 Sep; 49(9):916-920. PubMed ID: 35545886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group.
    Nikolaou V; Sibaud V; Fattore D; Sollena P; Ortiz-Brugués A; Giacchero D; Romano MC; Riganti J; Lallas K; Peris K; Voudouri D; Lallas A; Fabbrocini G; Lazaridou E; Carrera C; Annunziata MC; Rossi E; Patri A; Rigopoulos D; Stratigos AJ; Apalla Z
    J Am Acad Dermatol; 2021 May; 84(5):1310-1320. PubMed ID: 33279646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of de novo psoriasis secondary to atezolizumab in a patient with hepatocellular carcinoma.
    Lim JH; Lo Y
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1135-1136. PubMed ID: 36177804
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab.
    Rodríguez de Vera Gómez P; Tous Romero MDC; Morales Portillo C; Serrano Olmedo I; Martínez Brocca MA
    Endocrinol Diabetes Nutr (Engl Ed); 2021 May; 68(5):363-365. PubMed ID: 34556267
    [No Abstract]   [Full Text] [Related]  

  • 7. A Case of Ixekizumab-induced Psoriasiform Eruption.
    Oiwa T; Fujita M; Takase S; Nishimura Y; Ota M; Okada K; Tachibana T
    Acta Derm Venereol; 2019 Apr; 99(4):446-447. PubMed ID: 30723870
    [No Abstract]   [Full Text] [Related]  

  • 8. Rupioid psoriasis induced by pembrolizumab.
    Marti-Marti I; Gómez S; Riera-Monroig J; Carrera C; Mascaró JM
    Indian J Dermatol Venereol Leprol; 2020; 86(5):580-582. PubMed ID: 32719194
    [No Abstract]   [Full Text] [Related]  

  • 9. Psoriasis caused by pembrolizumab treatment in advanced melanoma: A positive prognostic side effect?
    D'Erme AM; Fidanzi C; Janowska A; Allegrini G; Barbara C; Cupini S; Viacava P; Bagnoni G
    Dermatol Ther; 2021 Sep; 34(5):e15050. PubMed ID: 34212457
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab.
    Rodríguez de Vera Gómez P; Tous Romero MDC; Morales Portillo C; Serrano Olmedo I; Martínez Brocca MA
    Endocrinol Diabetes Nutr (Engl Ed); 2021 May; 68(5):363-365. PubMed ID: 33214127
    [No Abstract]   [Full Text] [Related]  

  • 11. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
    Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
    J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atezolizumab-induced Sclerosing Cholangitis in a patient with lung cancer: A case report.
    Nabeshima S; Yamasaki M; Matsumoto N; Takaki S; Nishi Y; Kawamoto K; Taniwaki M; Ohashi N; Hattori N
    Cancer Treat Res Commun; 2021; 26():100270. PubMed ID: 33338849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaque Psoriasis Flare and Peripheral Edema in a Patient Treated With Atezolizumab.
    Santos-Juanes J; Munguía Calzada P; Álvarez Fernández C
    Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):410-411. PubMed ID: 30366590
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management [Formula: see text].
    Muntyanu A; Netchiporouk E; Gerstein W; Gniadecki R; Litvinov IV
    J Cutan Med Surg; 2021; 25(1):59-76. PubMed ID: 32746624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis onset with tocilizumab treatment for rheumatoid arthritis.
    Wendling D; Letho-Gyselinck H; Guillot X; Prati C
    J Rheumatol; 2012 Mar; 39(3):657. PubMed ID: 22383356
    [No Abstract]   [Full Text] [Related]  

  • 16. New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report.
    Currado D; Margiotta D; Conforti C; Coppola R; Panasiti V; Afeltra A; Navarini L
    Scand J Rheumatol; 2020 Jan; 49(1):75-76. PubMed ID: 31262212
    [No Abstract]   [Full Text] [Related]  

  • 17. Secukinumab treatment of tumor necrosis factor antagonists induced paradoxical psoriasis flares in a patient with plaque psoriasis.
    Zheng J; Li Y; Ding Y; Gao Y
    Dermatol Ther; 2020 Nov; 33(6):e14455. PubMed ID: 33107149
    [No Abstract]   [Full Text] [Related]  

  • 18. Psoriasis vulgaris triggered by treatment with mogamulizumab in a patient with cutaneous T-cell lymphoma.
    Lehner GM; Schacht V; Angela Y; Grimmelmann I; Gutzmer R
    J Dtsch Dermatol Ges; 2021 Sep; 19(9):1355-1358. PubMed ID: 34357675
    [No Abstract]   [Full Text] [Related]  

  • 19. Atezolizumab-induced pure red cell aplasia.
    Bennett R; Ruskova A
    Br J Haematol; 2021 Apr; 193(1):10. PubMed ID: 33583015
    [No Abstract]   [Full Text] [Related]  

  • 20. Ixekizumab-Induced Serum Sickness (Like Reaction): An Unusual Adverse Effect.
    Lindberg MR; Todd SP; Bunker DR; DeKlotz CMC
    J Clin Rheumatol; 2021 Dec; 27(8S):S469-S470. PubMed ID: 31804251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.